Nathan Treybeck
Stock Analyst at Wells Fargo
(2.77)
# 2,349
Out of 5,093 analysts
21
Total ratings
50%
Success rate
8.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $97 → $93 | $82.89 | +12.20% | 2 | Nov 7, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $58 → $51 | $35.00 | +45.71% | 9 | Nov 5, 2025 | |
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $71.60 | +11.73% | 4 | Oct 24, 2025 | |
| RMD ResMed | Initiates: Equal-Weight | $280 | $246.52 | +13.58% | 1 | Oct 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $180 | $173.63 | +3.67% | 5 | Aug 1, 2025 |
LeMaitre Vascular
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $97 → $93
Current: $82.89
Upside: +12.20%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Overweight
Price Target: $58 → $51
Current: $35.00
Upside: +45.71%
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $71.60
Upside: +11.73%
ResMed
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $280
Current: $246.52
Upside: +13.58%
iRhythm Technologies
Aug 1, 2025
Maintains: Overweight
Price Target: $130 → $180
Current: $173.63
Upside: +3.67%